Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin in Tibia Fractures
NCT00254514Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2001
- Primary completion
- Oct 2003
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of somatropin in Tibia Fracture (4 arms), sponsored by Novo Nordisk. Primary endpoint: Time from surgery until fracture has healed at 12 months. Started Aug 2001; status: completed.
02
Drugs
somatropin
03
Conditions
Tibia Fracture
Beyond the preview
Go deeper on NCT00254514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254514.